Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 1
1987 5
1988 4
1989 1
1990 2
1991 3
1992 1
1993 4
1994 1
1995 4
1996 3
1997 2
1998 1
1999 4
2000 1
2001 3
2002 3
2003 6
2004 3
2005 3
2006 4
2007 6
2008 4
2009 3
2010 7
2011 8
2012 5
2013 5
2014 3
2015 4
2016 3
2017 5
2018 8
2019 5
2020 4
2021 12
2022 21
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D. Cameroni E, et al. Among authors: geffner j. Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23. Nature. 2022. PMID: 35016195 Free PMC article.
Reply to Kao and Liaw.
Ochoa V, Díaz FE, Ramirez E, Fentini MC, Carobene M, Geffner J, Arruvito L, Remes Lenicov F. Ochoa V, et al. Among authors: geffner j. J Infect Dis. 2022 Aug 12;226(1):189. doi: 10.1093/infdis/jiac081. J Infect Dis. 2022. PMID: 35245935 No abstract available.
Purinergic signaling pathway in severe COVID-19.
Arruvito L, Sananez I, Seery V, Russo C, Geffner J. Arruvito L, et al. Among authors: geffner j. Curr Opin Pharmacol. 2023 Jun;70:102379. doi: 10.1016/j.coph.2023.102379. Epub 2023 Mar 23. Curr Opin Pharmacol. 2023. PMID: 37087844 Free PMC article. Review.
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults.
Pasquevich KA, Coria LM, Ceballos A, Mazzitelli B, Rodriguez JM, Demaría A, Pueblas Castro C, Bruno L, Saposnik L, Salvatori M, Varese A, González S, González Martínez VV, Geffner J, Álvarez D; Laboratorio Pablo Cassará R&D and CMC for ARVAC CG consortium; Feleder E, Halabe K, Perez Lera PE, de Oca FM, Vega JC, Lombardo M, Yerino GA, Fló J, Cassataro J. Pasquevich KA, et al. Among authors: geffner j. Nat Commun. 2023 Jul 28;14(1):4551. doi: 10.1038/s41467-023-40272-3. Nat Commun. 2023. PMID: 37507392 Free PMC article. Clinical Trial.
[Tribute to Martín Isturiz].
Geffner J. Geffner J. Medicina (B Aires). 2019;79(3):237-238. Medicina (B Aires). 2019. PMID: 31284264 Free article. Spanish. No abstract available.
Host response to respiratory syncytial virus infection.
Arruvito L, Raiden S, Geffner J. Arruvito L, et al. Among authors: geffner j. Curr Opin Infect Dis. 2015 Jun;28(3):259-66. doi: 10.1097/QCO.0000000000000159. Curr Opin Infect Dis. 2015. PMID: 25887611 Review.
164 results